| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/04/1998 | EP0652967B1 Self-assembling replication defective hybrid virus particles |
| 02/04/1998 | EP0651800B1 Basophil granule proteins |
| 02/04/1998 | EP0633944A4 Method of multiplex ligase chain reaction. |
| 02/04/1998 | EP0568537B1 Genetic modification of endothelial cells |
| 02/04/1998 | EP0506821B1 Hybrid protein c |
| 02/04/1998 | EP0500791B1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 02/04/1998 | EP0460072B1 Human elastase inhibitor |
| 02/04/1998 | EP0383837B1 Alveolar surfactant proteins |
| 02/04/1998 | CN1172503A Toxins from wasp bracon hebetor |
| 02/04/1998 | CN1172502A In vivo mutations and polymorphisms in 17 q -linked breast and ovarian cancer susceptibility gene |
| 02/04/1998 | CN1172116A Aprotinin variants having improved properties |
| 02/04/1998 | CN1172115A Method for preparing ox cranial nerve peptide FF |
| 02/03/1998 | US5714667 Mice lacking expression of CTLA-4 receptor |
| 02/03/1998 | US5714666 Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells |
| 02/03/1998 | US5714596 NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
| 02/03/1998 | US5714595 Mechanism-based screen for retinoid X receptor agonists and antagonists |
| 02/03/1998 | US5714593 Vaccines, medical diagnosis |
| 02/03/1998 | US5714590 Process for recovering a high-purity virus-inactivated factor VIII by anion exchanger chromatography |
| 02/03/1998 | US5714589 Method of selectively extracting osteogenic protein |
| 02/03/1998 | US5714588 Enhancement of cellular attachment using H3 protein |
| 02/03/1998 | US5714585 Antibodies that are immunoreactive with interleukin-7 |
| 02/03/1998 | US5714582 Invertebrate type V telopeptide collagen, methods of making, and use thereof |
| 02/03/1998 | US5714581 Antitumor agents, leukemia treatment |
| 02/03/1998 | US5714580 Trypsin Inhibitors |
| 02/03/1998 | US5714579 Technetium-99M labeled peptides for imaging inflammation |
| 02/03/1998 | US5714578 Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body |
| 02/03/1998 | US5714577 Antimicrobial peptides |
| 02/03/1998 | US5714576 Administering to stimulate melanin synthesis |
| 02/03/1998 | US5714575 Nucleic acids sequence, stress-induced proteins and uses thereof |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714467 Antibacterial and antimalarial hybrid peptides |
| 02/03/1998 | US5714466 Method of using acylation stimulating protein |
| 02/03/1998 | US5714465 Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor |
| 02/03/1998 | US5714464 Anti-viral mushroom extracts |
| 02/03/1998 | US5714459 Administering to treat demyelination in mammals |
| 02/03/1998 | US5714382 Isolated dna encoding feline interferon precursor having specified amino acid sequence |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | US5714371 Method for refolding insoluble aggregates of hepatitis C virus protease |
| 02/03/1998 | US5714363 Polypeptide synthetase having the catalytic hydrolysis activity, changing 3-exomethylenecephalosporin c to deacetylcephalosporin c |
| 02/03/1998 | US5714349 Cultivating escherichia coli transformed with plasmid under conditions suitable for expression of human parathyroid hormone |
| 02/03/1998 | US5714347 Preparation of recombinant ubiquitin cross-reactive protein (UCRP) with improved bioactivity |
| 02/03/1998 | US5714346 Process for production of human growth hormone using Bacillus Brevis |
| 02/03/1998 | US5714344 Protease-derivatized CVF |
| 02/03/1998 | US5714342 Using fluorescence analysis |
| 02/03/1998 | US5714334 Gene and method for production of an IgA binding protein |
| 02/03/1998 | US5714331 Incorporating an aminoalkyl side chain into the pna's which bind to complementary nucleobase sequences more tightly to form ?duplexes?; viricides; anticarcinogenic agents; enzyme inhibitors |
| 02/03/1998 | US5714316 Chimeric envelope proteins for viral targeting |
| 02/03/1998 | US5714314 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 02/03/1998 | US5714153 Administering antibody inducing dose of recombinant herpes simplex virus comprising synthetic herpes simplex virus promoter linked to heterologous gene |
| 02/03/1998 | US5714152 Herpes simplex virus VP16 vaccines |
| 02/03/1998 | US5714147 Binding endothelial cell with a fused lymphocyte homing receptor polypeptide to prevent the binding of a lymphocyte |
| 02/03/1998 | US5714146 Increasing osteoblast activity in mammal exhibiting decreased bone formation by administering interleukin-4 antagonist; osteoporosis treatment |
| 02/03/1998 | US5714140 Method for inhibiting the production of bioactive IL-1 by administering M-CSF |
| 02/03/1998 | US5714042 A paper sheet or board prepared from a mixture of solubilized collagen and cellulosic pulp (virgin, broke or reclaimed) with good tensile, burst and tear strength |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 02/03/1998 | CA1339654C Gene therapy using gene fusion for genetic or acquired disorders |
| 02/01/1998 | CA2182421A1 Phosphate starvation-inducible proteins |
| 01/29/1998 | WO1998003872A2 Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg |
| 01/29/1998 | WO1998003683A1 Dna encoding canine von willebrand factor and methods of use |
| 01/29/1998 | WO1998003682A1 Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 01/29/1998 | WO1998003673A1 High fidelity detection of nucleic acid differences by ligase detection reaction |
| 01/29/1998 | WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | WO1998003669A2 Vectors for inhibiting hiv and tumor growth |
| 01/29/1998 | WO1998003666A1 Recombinant vectors |
| 01/29/1998 | WO1998003664A1 DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS |
| 01/29/1998 | WO1998003660A1 Feline polynucleotide vaccine formula |
| 01/29/1998 | WO1998003659A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | WO1998003658A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 01/29/1998 | WO1998003657A1 Viral interleukin-6 |
| 01/29/1998 | WO1998003656A1 Recombinant sef14 fimbrial protein from salmonella |
| 01/29/1998 | WO1998003655A2 Gene expression regulatory dna, expression cassette, expression vector and transgenic plant |
| 01/29/1998 | WO1998003654A2 High-affinity interleukin-4 muteins |
| 01/29/1998 | WO1998003652A2 P300/cbp-associated transcriptional co-factor p/caf and uses thereof |
| 01/29/1998 | WO1998003651A1 Human osteoclast-specific and -related dna sequences |
| 01/29/1998 | WO1998003650A1 Ninjurin |
| 01/29/1998 | WO1998003649A1 Constructs and complexes of cyclin e |
| 01/29/1998 | WO1998003648A1 Fas ligand-like protein, its production and use |
| 01/29/1998 | WO1998003645A1 Transmembrane trapping methods |
| 01/29/1998 | WO1998003644A1 Transgenic animal model for alzheimer disease |
| 01/29/1998 | WO1998003643A2 Transgenic animals with mutant human app or a4ct sequences |
| 01/29/1998 | WO1998003635A1 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same |
| 01/29/1998 | WO1998003634A1 Methods for identifying vasoprotective agents |
| 01/29/1998 | WO1998003632A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | WO1998003631A1 Method of increasing growth and yield in plants |
| 01/29/1998 | WO1998003552A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 01/29/1998 | WO1998003551A1 Cd6 ligand |
| 01/29/1998 | WO1998003549A1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF |
| 01/29/1998 | WO1998003548A1 A novel galanin receptor |
| 01/29/1998 | WO1998003547A1 Antagonists of intestinotrophic glp-2 peptides |
| 01/29/1998 | WO1998003546A1 Analogs of cationic proteins |
| 01/29/1998 | WO1998003545A1 Protein and gene for antioxidant response |
| 01/29/1998 | WO1998003544A1 IDENTIFICATION OF SHORT PEPTIDE SEQUENCES REPRESENTING EPITOPES OF GLYCOPROTEIN G OF HSV-2 USING A PHAGE PEPTIDE DISPLAY LIBRARY FOR USE IN AN ANTI-gG2 ELISA |
| 01/29/1998 | WO1998003543A1 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library |
| 01/29/1998 | WO1998003542A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | WO1998003541A1 Conantokins |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003538A2 Signal-regulated, cleavage-mediated toxins |
| 01/29/1998 | WO1998003537A2 Hirustasin and a hirustasin/kallikrein complex in crystalline form |
| 01/29/1998 | WO1998003536A1 Chemically-inducible arabidopsis pr-1 promoter |